EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Development of Novel Furan–Chalcone Derivatives as Targeting Bacterial DNA Gyrase and Topoisomerase IV: Design, Synthesis, and In Silico Studies

Nagaraj N Durgadasheemi iD, Vishal Cs

Chemistry & Biodiversity · 2026-11 · 23 (11)

DOI: 10.1002/cbdv.71869 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 31.10.2026. Verfasst von Nagaraj N Durgadasheemi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, R R College of Pharmacy, Bengaluru, India. Hauptthemen laut MEDLINE: DNA Topoisomerase IV, DNA Gyrase, Anti-Bacterial Agents, Topoisomerase II Inhibitors. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of novel furan–chalcone derivatives ( Na1–Na8 ) were synthesized and evaluated for their antimicrobial, antioxidant, DNA gyrase inhibitory, and computational properties using integrated in vitro and in silico approaches. Among the synthesized compounds, Na5 exhibited the most potent antibacterial activity with low MIC values against both Gram‐positive and Gram‐negative bacterial strains. Antioxidant studies revealed significant free radical scavenging activity for Na3 , Na4 , and Na5 . Molecular docking studies against DNA gyrase B demonstrated favorable binding interactions within the ATP‐binding pocket. Enzyme inhibition studies against Escherichia coli DNA gyrase and topoisomerase IV confirmed that Na5 showed the strongest inhibitory activity among the tested compounds. ADME predictions indicated acceptable drug‐likeness and pharmacokinetic properties. Furthermore, DFT analysis of Na5 revealed a suitable HOMO–LUMO energy gap and favorable electronic properties supporting its biological activity. Overall, the results identify Na5 as a promising lead candidate for the development of novel antimicrobial agents targeting bacterial DNA gyrase and topoisomerase IV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA Topoisomerase IVDNA GyraseAnti-Bacterial AgentsTopoisomerase II InhibitorsDrug DesignFuransChalconesMolecular Docking SimulationStructure-Activity RelationshipMicrobial Sensitivity TestsMolecular StructureEscherichia coliAntioxidantsGram-Positive BacteriaGram-Negative Bacteria

Stichwörter der Autor:innen

ADME predictionDNA gyrase inhibitionFuran–chalconesantimicrobial activityantioxidant activitymolecular docking

Substanzen

DNA Topoisomerase IVDNA GyraseAnti-Bacterial AgentsTopoisomerase II InhibitorsFuransChalconesAntioxidants

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, R R College of Pharmacy, Bengaluru, India.
  • Department of Pharmaceutics, R R College of Pharmacy, Bengaluru, India.

ORCID-Profile: Nagaraj N Durgadasheemi

Zitieren

APA

Durgadasheemi, N. N., & Cs, V. (2026). Development of Novel Furan–Chalcone Derivatives as Targeting Bacterial DNA Gyrase and Topoisomerase IV: Design, Synthesis, and In Silico Studies. Chemistry & Biodiversity, 23(11). https://doi.org/10.1002/cbdv.71869

Vancouver

Durgadasheemi NN, Cs V. Development of Novel Furan–Chalcone Derivatives as Targeting Bacterial DNA Gyrase and Topoisomerase IV: Design, Synthesis, and In Silico Studies. Chemistry & Biodiversity. 2026;23(11). doi:10.1002/cbdv.71869

BibTeX
@article{Durgadasheemi2026,
  author = {Durgadasheemi, Nagaraj N and Cs, Vishal},
  title = {Development of Novel Furan–Chalcone Derivatives as Targeting Bacterial DNA Gyrase and Topoisomerase IV: Design, Synthesis, and In Silico Studies},
  journal = {Chemistry & Biodiversity},
  year = {2026},
  volume = {23},
  number = {11},
  doi = {10.1002/cbdv.71869}
}
Kostenlos starten →